Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza vs Prednisolone Acetate After Cataract Surgery in Diabetic Patients
NCT04977427Phase 4Withdrawn
- Sponsor
- Baylor Scott & White Research Institute
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
01
Overview
A Phase 4 trial of ozurdex in post-operative inflammation, macular edema, sponsored by Baylor Scott & White Research Institute. Planned start Aug 2021; status: withdrawn.
02
Drugs
ozurdex
03
Conditions
post-operative inflammationmacular edema
Beyond the preview
Go deeper on NCT04977427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04977427.